GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Knight Therapeutics Inc (TSX:GUD) » Definitions » Forward Dividend Yield %

Knight Therapeutics (TSX:GUD) Forward Dividend Yield % : 0.00% (As of May. 24, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Knight Therapeutics Forward Dividend Yield %?

As of today (2024-05-24), the Forward Annual Dividend Yield of Knight Therapeutics is 0.00%.

As of today (2024-05-24), the Trailing Annual Dividend Yield of Knight Therapeutics is 0.00%.

TSX:GUD's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.845
* Ranked among companies with meaningful Forward Dividend Yield % only.

Knight Therapeutics's Dividends per Share for the three months ended in Mar. 2024 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Knight Therapeutics's Forward Dividend Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Knight Therapeutics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Knight Therapeutics's Forward Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Knight Therapeutics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Knight Therapeutics's Forward Dividend Yield % falls into.



Knight Therapeutics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Knight Therapeutics  (TSX:GUD) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Knight Therapeutics Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Knight Therapeutics's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Knight Therapeutics (TSX:GUD) Business Description

Traded in Other Exchanges
Address
3400 De Maisonneuve West, Suite 1055, Montreal, QC, CAN, H3Z 3B8
Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices in Canada, Ltin America and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
Executives
Sime Armoyan 10% Security Holder

Knight Therapeutics (TSX:GUD) Headlines

No Headlines